MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

therapeutic resistance

Search medical newsFind research, conditions and clinical updates
  • Home
  • therapeutic resistance
揭秘儿童 B-ALL 复发的基因组驱动因素：来自 Children’s Oncology Group 试验的启示
Posted inClinical Updates Hematology-Oncology Pediatrics

Unraveling Genomic Drivers of Relapse in Childhood B-ALL: Insights from the Children’s Oncology Group Trial

Posted by By MedXY 11/09/2026
This article analyzes novel genomic alterations linked to relapse in childhood B-acute lymphoblastic leukemia (B-ALL), revealing subtype-specific mechanisms of therapeutic resistance and implications for personalized treatment strategies.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Cost-Effectiveness of Visual Scanning Training for Post-Stroke Hemianopia: Insights from the SEARCH Trial and Related Evidence
  • Childhood Famine and Its Impact on Late-Life Tooth Loss: Unraveling the Role of Age Confounding
  • Neoadjuvant Immunotherapy in dMMR Colon Cancer: A Breakthrough in Survival Outcomes
  • Dupilumab in Pediatric Eosinophilic Esophagitis: Efficacy, Safety, and Translational Insights from Recent Clinical Evidence
  • Exploring HFE Genotype-Linked Arthropathy Beyond Genetic Haemochromatosis: Clinical and Pathophysiological Insights
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top